{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:51:23Z","timestamp":1790779883052,"version":"4.1.0"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["North Am J Med Sci"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/1947-2714.170600","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T02:04:34Z","timestamp":1448849074000},"page":"483","source":"Crossref","is-referenced-by-count":239,"title":["Hypercalcemia of malignancy: An update on pathogenesis and management"],"prefix":"10.4103","volume":"7","author":[{"given":"AibekE","family":"Mirrakhimov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1947-2714.170600-1","first-page":"954","volume-title":"Investigation of hypercalcemia","author":"Endres","year":"2012","journal-title":"Clin Biochem"},{"key":"key-10.4103\/1947-2714.170600-2","first-page":"704","volume-title":"Incidence of hypercalcemia and malignant neoplasm","author":"Burt","year":"1980","journal-title":"Arch Surg"},{"key":"key-10.4103\/1947-2714.170600-3","first-page":"1309","volume-title":"Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center","author":"Vassilopoulou-Sellin","year":"1993","journal-title":"Cancer"},{"key":"key-10.4103\/1947-2714.170600-4","first-page":"373","volume-title":"Hypercalcemia associated with cancer","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1947-2714.170600-5","first-page":"499","volume-title":"Cancer-associated hypercalcemia: Morbidity and mortality.Clinical experience in 126 treated patients","author":"Ralston","year":"1990","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1947-2714.170600-6","doi-asserted-by":"crossref","unstructured":"Hamilton F, Carroll R, Hamilton W, Salisbury C The risk of cancer in primary care patients with hypercalcaemia: A cohort study using electronic records. Br J Cancer 2014;111:1410-2.","DOI":"10.1038\/bjc.2014.433"},{"key":"key-10.4103\/1947-2714.170600-7","first-page":"1415","volume-title":"Non-malignant causes of hypercalcemia in cancer patients: A frequent and neglected occurrence","author":"Soyfoo","year":"2013","journal-title":"Support Care Cancer"},{"key":"key-10.4103\/1947-2714.170600-8","first-page":"1409","volume-title":"Writing a narrative biomedical review: Considerations for authors, peer reviewers, and editors","author":"Gasparyan","year":"2011","journal-title":"Rheumatol Int"},{"key":"key-10.4103\/1947-2714.170600-9","first-page":"387","volume-title":"Mechanisms of intestinal calcium absorption","author":"Bronner","year":"2003","journal-title":"J Cell Biochem"},{"key":"key-10.4103\/1947-2714.170600-10","unstructured":"Hall JE. Guyton and Hall Textbook of Medical Physiology. 12 th ed. Saunders, 2010; p. 955-972."},{"key":"key-10.4103\/1947-2714.170600-11","first-page":"131","volume-title":"The skeleton: A multi-functional complex organ: The role of key signalling pathways in osteoclast differentiation and in bone resorption","author":"Mellis","year":"2011","journal-title":"J Endocrinol"},{"key":"key-10.4103\/1947-2714.170600-12","first-page":"490","volume-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"key-10.4103\/1947-2714.170600-13","first-page":"1221","volume-title":"Role of rank ligand in mediating increased bone resorption in early postmenopausal women","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin invest"},{"key":"key-10.4103\/1947-2714.170600-14","first-page":"337","volume-title":"Osteoclast differentiation and activation","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"key-10.4103\/1947-2714.170600-15","doi-asserted-by":"crossref","unstructured":"Wysolmerski JJ. Parathyroid hormone-related protein: An update. J Clin Endocrinol Metab 2012;97:2947-56.","DOI":"10.1210\/jc.2012-2142"},{"key":"key-10.4103\/1947-2714.170600-16","first-page":"3","volume-title":"Biology of breast cancer bone metastasis","author":"Akhtari","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"key-10.4103\/1947-2714.170600-17","first-page":"822","volume-title":"TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling","author":"Johnson","year":"2011","journal-title":"Cancer Res"},{"key":"key-10.4103\/1947-2714.170600-18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-60761-554-5","volume-title":"Pathogenesis of myeloma bone disease","author":"Roodman","year":"2010","journal-title":"J Cell Biochem"},{"key":"key-10.4103\/1947-2714.170600-19","first-page":"229","volume-title":"Hypercalcaemia due to calcium binding by a polymeric IgA kappa-paraprotein","author":"Pearce","year":"1991","journal-title":"Ann clin biochem"},{"key":"key-10.4103\/1947-2714.170600-20","first-page":"580","volume-title":"Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene","author":"VanHouten","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1947-2714.170600-21","first-page":"49","volume-title":"Use of denosumab in parathyroid carcinoma with refractory hypercalcemia","author":"Tong","year":"2015","journal-title":"QJM"},{"key":"key-10.4103\/1947-2714.170600-22","first-page":"28","volume-title":"Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism","author":"Hutchesson","year":"1995","journal-title":"Postgrad Med J"},{"key":"key-10.4103\/1947-2714.170600-23","first-page":"3127","volume-title":"Concurrence of primary hyperparathyroidism and metastatic breast carcinoma affected a parathyroid gland","author":"Lee","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1947-2714.170600-24","first-page":"420565","volume-title":"A case of multiple myeloma coexisting with primary hyperparathyroidism and review of the literature","author":"Hussain","year":"2013","journal-title":"Case Rep Oncol Med"},{"key":"key-10.4103\/1947-2714.170600-25","first-page":"69","volume-title":"Understanding hypercalcemia.Its metabolic basis, signs, and symptoms","author":"Inzucchi","year":"2004","journal-title":"Postgrad Med"},{"key":"key-10.4103\/1947-2714.170600-26","first-page":"2465","volume-title":"Posterior reversible encephalopathy syndrome due to hypercalcemia associated with parathyroid hormone-related peptide: A case report and review of the literature","author":"Nakajima","year":"2013","journal-title":"Intern Med"},{"key":"key-10.4103\/1947-2714.170600-27","first-page":"1112","volume-title":"Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: Physiopathological considerations","author":"Camara-Lemarroy","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1947-2714.170600-28","first-page":"309","volume-title":"Reversible renal failure caused by hypercalcemia.A retrospective study","author":"Lins","year":"1978","journal-title":"Acta Med Scand"},{"key":"key-10.4103\/1947-2714.170600-29","doi-asserted-by":"crossref","unstructured":"Caruana RJ, Buckalew VM Jr. The syndrome of distal renal tubular acidosis. Clinical and laboratory findings in 58 cases. Medicine Baltimore. 1988;67:84-99.","DOI":"10.1097\/00005792-198803000-00002"},{"key":"key-10.4103\/1947-2714.170600-30","first-page":"197","volume-title":"Primary hyperparathyroidism and the gastrointestinal tract","author":"Gardner","year":"1981","journal-title":"South Med J"},{"key":"key-10.4103\/1947-2714.170600-31","first-page":"716","volume-title":"Small cell carcinoma of the ovary with hypercalcemia causes severe pancreatitis and altered mental status","author":"Wynn","year":"2004","journal-title":"Gynecol oncol"},{"key":"key-10.4103\/1947-2714.170600-32","first-page":"153","volume-title":"Electrocardiographic manifestations: Electrolyte abnormalities","author":"Diercks","year":"2004","journal-title":"J Emerg Med"},{"key":"key-10.4103\/1947-2714.170600-33","first-page":"340","volume-title":"Hypercalcemia due to Vitamin D intoxication with clinical features mimicking acute myocardial infarction","author":"Ashizawa","year":"2003","journal-title":"Intern Med"},{"key":"key-10.4103\/1947-2714.170600-34","first-page":"298","volume-title":"Hypercalcemia-induced ST-segment elevation mimicking acute myocardial infarction","author":"Nishi","year":"2006","journal-title":"J Electrocardiol"},{"key":"key-10.4103\/1947-2714.170600-35","first-page":"999","volume-title":"ST segment elevation mimicking acute myocardial infarction in hypercalcaemia","author":"Turhan","year":"2005","journal-title":"Heart"},{"key":"key-10.4103\/1947-2714.170600-36","first-page":"94","volume-title":"Ventricular fibrillation in hypercalcaemic crisis due to primary hyperparathyroidism","author":"Kiewiet","year":"2004","journal-title":"Neth J Med"},{"key":"key-10.4103\/1947-2714.170600-37","first-page":"S51","volume-title":"Differential diagnosis of hypercalcemia","author":"Lafferty","year":"1991","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/1947-2714.170600-38","first-page":"393","volume-title":"Relationship of free and total calcium in hypercalcemic conditions","author":"Ladenson","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1947-2714.170600-39","first-page":"10","volume-title":"Malignancy and concomitant primary hyperparathyroidism","author":"Strodel","year":"1988","journal-title":"J Surg Oncol"},{"key":"key-10.4103\/1947-2714.170600-40","first-page":"83","volume-title":"Parathyroid hormone expression in a patient with metastatic nasopharyngeal rhabdomyosarcoma and hypercalcemia","author":"Wong","year":"2005","journal-title":"Endocrine"},{"key":"key-10.4103\/1947-2714.170600-41","first-page":"781","volume-title":"Primary hyperparathyroidism","author":"Bilezikian","year":"2012","journal-title":"Endocr Pract"},{"key":"key-10.4103\/1947-2714.170600-42","first-page":"25","volume-title":"Parathyroid nuclear scan.A focused review on the technical and biological factors affecting its outcome","author":"Kannan","year":"2014","journal-title":"Clin cases miner bone metab"},{"key":"key-10.4103\/1947-2714.170600-43","first-page":"1611","volume-title":"Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia","author":"Gurney","year":"1993","journal-title":"Lancet"},{"key":"key-10.4103\/1947-2714.170600-44","first-page":"2223","volume-title":"Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate","author":"Wimalawansa","year":"1994","journal-title":"Cancer"},{"key":"key-10.4103\/1947-2714.170600-45","first-page":"1268","volume-title":"Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients","author":"Pecherstorfer","year":"1994","journal-title":"J Clin endocrinol metab"},{"key":"key-10.4103\/1947-2714.170600-46","first-page":"206","volume-title":"Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate APD","author":"Ling","year":"1995","journal-title":"Br J Cancer"},{"key":"key-10.4103\/1947-2714.170600-47","first-page":"234","volume-title":"Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone related peptide and 1,25-dihydroxy Vitamin D in a patient with metastatic renal cell carcinoma","author":"Shivnani","year":"2009","journal-title":"Endocr Pract"},{"key":"key-10.4103\/1947-2714.170600-48","first-page":"473","volume-title":"Rehydration in the treatment of severe hypercalcaemia","author":"Hosking","year":"1981","journal-title":"Q J Med"},{"key":"key-10.4103\/1947-2714.170600-49","first-page":"259","volume-title":"Narrative review: Furosemide for hypercalcemia: An unproven yet common practice","author":"LeGrand","year":"2008","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1947-2714.170600-50","first-page":"1268","volume-title":"The effects of calcitonin in hypercalcemia in patients with malignancy","author":"Vaughn","year":"1974","journal-title":"Cancer"},{"key":"key-10.4103\/1947-2714.170600-51","first-page":"18","volume-title":"Nasal human calcitonin for tumor-induced hypercalcemia","author":"Dumon","year":"1992","journal-title":"Calcif tissue Int"},{"key":"key-10.4103\/1947-2714.170600-52","first-page":"S26","volume-title":"Salmon calcitonin in the acute management of hypercalcemia","author":"Wisneski","year":"1990","journal-title":"Calcif tissue Int"},{"key":"key-10.4103\/1947-2714.170600-53","doi-asserted-by":"crossref","unstructured":"Austin LA, Heath H 3 rd . Calcitonin: Physiology and pathophysiology. N Engl J Med 1981;304:269-78.","DOI":"10.1056\/NEJM198101293040505"},{"key":"key-10.4103\/1947-2714.170600-54","first-page":"303","volume-title":"Basic research and clinical applications of bisphosphonates in bone disease: What have we learned over the last 40 years?","author":"Xu","year":"2013","journal-title":"J Transl Med"},{"key":"key-10.4103\/1947-2714.170600-55","first-page":"209","volume-title":"Bisphosphonates: An update on mechanisms of action and how these relate to clinical efficacy","author":"Russell","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/1947-2714.170600-56","first-page":"558","volume-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials","author":"Major","year":"2001","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/1947-2714.170600-57","first-page":"539","volume-title":"Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: A randomized multicentric comparison to pamidronate","author":"Pecherstorfer","year":"2003","journal-title":"Support care cancer"},{"key":"key-10.4103\/1947-2714.170600-58","first-page":"1935","volume-title":"Treatment of cancer-associated hypercalcemia.Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone","author":"Gucalp","year":"1994","journal-title":"Arch intern med"},{"key":"key-10.4103\/1947-2714.170600-59","unstructured":"Machado CE, Flombaum CD safety of pamidronate in patients with renal failure and hypercalcemia. Clin nephrol 1996;45:175-9."},{"key":"key-10.4103\/1947-2714.170600-60","first-page":"447","volume-title":"Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure","author":"Davenport","year":"1993","journal-title":"Scand J Urol Nephrol"},{"key":"key-10.4103\/1947-2714.170600-61","first-page":"459","volume-title":"Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient","author":"Trimarchi","year":"2006","journal-title":"Nat clin pract nephrol"},{"key":"key-10.4103\/1947-2714.170600-62","first-page":"1341","volume-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","author":"Saad","year":"2012","journal-title":"Ann oncol"},{"key":"key-10.4103\/1947-2714.170600-63","first-page":"1139","volume-title":"Denosumab: Mechanism of action and clinical outcomes","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"key":"key-10.4103\/1947-2714.170600-64","first-page":"1417","volume-title":"Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment","author":"Hu","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/1947-2714.170600-65","doi-asserted-by":"crossref","unstructured":"Adhikaree J, Newby Y, Sundar S. Denosumab should be the treatment of choice for bisphosphonate refractory hypercalcaemia of malignancy. BMJ Case Rep 2014;2014. pii: bcr2013202861.","DOI":"10.1136\/bcr-2013-202861"},{"key":"key-10.4103\/1947-2714.170600-66","first-page":"K1","volume-title":"Refractory hypercalcaemia secondary to parathyroid carcinoma: Response to high-dose denosumab","author":"Karuppiah","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1947-2714.170600-67","first-page":"906","volume-title":"Denosumab for tumor-induced hypercalcemia complicated by renal failure","author":"Bech","year":"2012","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1947-2714.170600-68","first-page":"e207","volume-title":"Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction","author":"Cicci","year":"2014","journal-title":"Clin lymphoma myeloma leuk"},{"key":"key-10.4103\/1947-2714.170600-69","first-page":"3144","volume-title":"Denosumab for treatment of hypercalcemia of malignancy","author":"Hu","year":"2014","journal-title":"J Clin endocrinol metab"},{"key":"key-10.4103\/1947-2714.170600-70","first-page":"756","volume-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1947-2714.170600-71","first-page":"765","volume-title":"Vitamin D metabolite-mediated hypercalcemia","author":"Adams","year":"1989","journal-title":"Endocrinol metab clin north am"},{"key":"key-10.4103\/1947-2714.170600-72","first-page":"142","volume-title":"Corticosteroid-induced clinical adverse events: Frequency, risk factors and patient\u2032s opinion","author":"Fardet","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/1947-2714.170600-73","first-page":"1083","volume-title":"Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent","author":"Collins","year":"1998","journal-title":"J Clin endocrinol metab"},{"key":"key-10.4103\/1947-2714.170600-74","first-page":"3803","volume-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","author":"Silverberg","year":"2007","journal-title":"J Clin endocrinol metab"},{"key":"key-10.4103\/1947-2714.170600-75","first-page":"1487","volume-title":"Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia","author":"Warrell","year":"1984","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1947-2714.170600-76","first-page":"292","volume-title":"Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases","author":"Warrell","year":"1987","journal-title":"J Clin oncol"},{"key":"key-10.4103\/1947-2714.170600-77","first-page":"211","volume-title":"Gallium inhibits bone resorption by a direct effect on osteoclasts","author":"Hall","year":"1990","journal-title":"Bone miner"},{"key":"key-10.4103\/1947-2714.170600-78","first-page":"669","volume-title":"Gallium nitrate for acute treatment of cancer-related hypercalcemia.A randomized, double-blind comparison to calcitonin","author":"Warrell","year":"1988","journal-title":"Ann Int Med"},{"key":"key-10.4103\/1947-2714.170600-79","first-page":"47","volume-title":"Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia","author":"Cvitkovic","year":"2006","journal-title":"Cancer J"},{"key":"key-10.4103\/1947-2714.170600-80","first-page":"424","volume-title":"Calcium-free hemodialysis for the management of hypercalcemia","author":"Koo","year":"1996","journal-title":"Nephron"},{"key":"key-10.4103\/1947-2714.170600-81","first-page":"288","volume-title":"Correction of hypercalcemia and hypophosphatemia by hemodialysis using a conventional, calcium-containing dialysis solution enriched with phosphorus","author":"Leehey","year":"1997","journal-title":"Am J Kidney Dis"}],"container-title":["North American Journal of Medical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T21:58:10Z","timestamp":1567375090000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.najms.org\/text.asp?2015\/7\/11\/483\/170600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"alternative-id":["170600"],"URL":"https:\/\/doi.org\/10.4103\/1947-2714.170600","relation":{},"ISSN":["1947-2714"],"issn-type":[{"value":"1947-2714","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}